Christine Chen

Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial

Craig B. Reeder, Donna Reece, Vishal Kukreti et al. · Leukemia · 2009 · 371 citations · Full text

Medicine, Hematology, Oncology +15

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

Meletios Α. Dimopoulos, Christine Chen, Andrew Spencer et al. · Leukemia · 2009 · 360 citations

Medicine, Oncology, Pharmacotherapy +15

Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma

Jean‐Luc Harousseau, Meletios Α. Dimopoulos, M. Wang et al. · Haematologica · 2010 · 112 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer

Cheng Jin, Yuming Jiang, Heng Yu et al. · British journal of surgery · 2020 · 76 citations · Full text

Medicine, Oncology, Surgery +17

Early relapse after single auto-SCT for multiple myeloma is a major predictor of survival in the era of novel agents

Víctor H. Jiménez‐Zepeda, Donna Reece, Suzanne Trudel et al. · Bone Marrow Transplantation · 2014 · 58 citations

Medicine, Oncology, Immunotherapy +10